In conclusion, we found that HPSE2 expression was downregulated in experimental glomerular disease models for glomerulonephritis, diabetic nephropathy and adriamycin nephropathy, a model for FSGS, which is suggested to be linked to the increased HPSE1 activity in these diseases. This evidence concerns the gene HPSE and glomerular disorder.